NCT03011242View on ClinicalTrials.gov

DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Psoriatic Arthritis
Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Rochester

OTHER

NCT03011242 - DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA | Biotech Hunter | Biotech Hunter